S- (2,3- bispalmitoyloxypropyl)- cysteinyl- amido- monomethoxyl polyethylene glycol

an immunologic adjuvant

Also Known As:

BPPcysMPEG

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Organic Chemicals: 133
- Alcohols: 595
  - Glycols: 38
    - Ethylene Glycols: 8
      - Polyethylene Glycols: 3865
        S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2
Macromolecular Substances: 97
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2
Biomedical and Dental Materials
- Polymers: 13051
  - Polyethylene Glycols: 3865
    - S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2
Technology, Industry, and Agriculture
- Manufactured Materials
  - Biomedical and Dental Materials
    - Polymers: 13051
      - Polyethylene Glycols: 3865
        S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2
Lipids: 114793
- Lipopeptides: 626
  - S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Lipopeptides: 626
    - S-(2,3-bispalmitoyloxypropyl)-cysteinyl-amido-monomethoxyl polyethylene glycol: 2

1.	Chandel, Himanshu Singh: 1 article (10/2014)
2.	Ebensen, Thomas: 1 article (10/2014)
3.	Guzman, Carlos A: 1 article (10/2014)
4.	Jha, Mukesh Kumar: 1 article (10/2014)
5.	Pandey, Surya Prakash: 1 article (10/2014)
6.	Saha, Bhaskar: 1 article (10/2014)
7.	Selvaraj, Sathishkumar: 1 article (10/2014)
8.	Shukla, Divanshu: 1 article (10/2014)
9.	Srivastava, Sunit: 1 article (10/2014)
10.	Braun, A: 1 article (01/2011)

1.	Inflammation (Inflammations) 01/01/2011 - "Based on this finding, the potential of BPPcysMPEG to reduce allergic airway inflammation by preventive modulation of the innate immune system via TLR2/6 agonization was investigated in mice. " 01/01/2011 - "Local treatment with BPPcysMPEG reduces allergic airway inflammation in sensitized mice."
2.	Infections 10/01/2014 - "major infection but reduced TLR9 expression, whereas pegylated bisacycloxypropylcysteine (BPPcysMPEG; TLR2-TLR6 ligand) reduced L. "
3.	Hypersensitivity (Allergy) 01/01/2011 - "In a human in vitro allergy model the potential of the TLR2/6 agonist BPPcysMPEG to modulate antigen presenting cells and allergen-specific immune responses was evaluated. "